{
    "domain": "alchemer.eu",
    "owner": {},
    "source": [
        "DuckDuckGo-US"
    ],
    "prevalence": 0.0000208,
    "sites": 3,
    "subdomains": [
        "survey"
    ],
    "cnames": [],
    "fingerprinting": 0,
    "resources": [
        {
            "rule": "alchemer\\.eu\\/s3\\/90363494\\/All-Sites-Sentiment-Poll-Technology-Poll-03-Q3-21-Technologies-Hype-or-Substance",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "5e6699e7c47e13c11fd803381e9636f115e46685b0227a8fdd8f70c80490cf68"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "aerospace-technology.com",
                "www.aerospace-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90370820\\/FS-Poll-13-Top-3-operational-challenges-for-financial-service-providers",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "aerospace-technology.com",
                "www.aerospace-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90370814\\/Insurance-Poll-12-Insurance-products-best-suited-for-digital-bancassurance",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000006943142605205969
            },
            "exampleSites": [
                "aerospace-technology.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90326348\\/All-Sites-COVID-19-Vaccination-Poll-01",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000006943142605205969
            },
            "exampleSites": [
                "aerospace-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90358850\\/Wearables-Poll-01-Wearables-Awareness-Usage",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "a37aa5bf5c929e0767c9358052d1a30549ba92a3508d93611b1d9ad0351ae4d5"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90337851\\/T-T-Poll-18-Preferred-length-of-stay-for-leisure-trip",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "bdf14899658745dedaa6ea67d2a5d9405a9edbcc2a9e86f78fd71705e31e9e95"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90359220\\/ADS-Poll-49-Impact-area-of-3D-printing",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "3b428f3ce079f6ec50f857384dffcaddaa1c5e474824bc86e31815e989c48220"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90358855\\/Wearables-Poll-2-Wearables-Functionalities",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "e11fc67bfce4a97cd0d7716565e0a83daeb5f9c8262b91ae3e0554f3486089ab"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90358869\\/Streaming-Services-Poll-4-Streaming-Services-Spend-Analysis",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "e0c9df3f944d164b6b19adb8d8996d07a49cb2c00c8967c552dc98655ef2f227"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90330010\\/All-Sites-WFH-poll-2-Q1-2021",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "8ad1dd7a770b5bf7685ccc3276a938203353bd31fc6ff44f98ca87752b5145ba"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90325279\\/ADS-Poll-39-Change-in-M-A-intensity-in-2021",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "12afa1f5e0069c4fee36e3604cd4bd831d050c4de103874cad623fa27ebc18fe"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90329002\\/ADS-Poll-43-Impact-of-lithium-ion-batteries-on-submarine-market",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "50d137bc640f0a5b85e12002cb6498475499a0af155705916d823f9e7c9ff034"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90359219\\/ADS-Poll-48-Integration-of-EVs-into-Armed-forces",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "b7e9172c671d04cbae6238173ad9786202458d32f300c17a9be2a071cb21cbaa"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90358866\\/Streaming-Services-Poll-2-Streaming-Services-Drivers",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "494a259f79d33b9e381b44383d6562b4bc2b1f213745ac8a97d10b9ff1a66e62"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90358862\\/Streaming-Services-Poll-01-Streaming-Services-Awareness-Usage",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "7396196980a8b45c2fd5191b94bf32120cc3dd00503b4ea4d8eaf96d840ecc1b"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90358861\\/Wearables-Poll-4-Wearables-Spend-Analysis",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "af0206f55659c5cffb8192da15e3956ea6399483ab9c3eaded0cc5c46c36821d"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90358857\\/Wearables-Poll-3-Wearables-Challenges-Concerns",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "8f61073a768d395d4f75d180e41cc19b236a35d8f3d09d61b55c42962d4afeb4"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90329022\\/ADS-Poll-46-Impact-of-European-budget-deficits-on-joint-programs",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "e8d56b8307d52eb606289401444f31d8fbafeb9c077af64e74c21a1819210413"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344124\\/CTA-Poll-15-Addressing-clinical-trial-disruptions",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "10d2ce8c0bcc77163a2c653a3cb24e268f87ced60392012d2c621cda4002ad96"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344125\\/CTA-Poll-16-Primary-reason-for-using-the-virtual-trial-model",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "81804cd32a7ea7626d5d88901962eeefd58fd6f0dc4a7b975525ca20f300f9ab"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344129\\/CTA-Poll-20-Relevance-of-data-governance-or-privacy",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "2892aff55f61fee72d7e121e7b0d84bf54d8961d275a284942a9289cdeb09b76"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344115\\/CTA-Poll-11-Decentralized-virtual-clinical-trials-due-to-Covid-19",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "eb6536cfe088e72624e3b119c4cbfb6e7dd86d7bc5f4188c85a1ed4f41dca0f4"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90350246\\/Pharma-Poll-43-Main-benefit-of-integrating-digital-tools-into-trials",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "3b7b57367c6731a3e1c38dfe7bad667424030c3445e41c09bda90fddbed1a321"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344126\\/CTA-Poll-17-Cost-of-decentralized-virtual-clinical-trials-vs-traditional-trials",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "22c7bb5beb088f26e44778ff2f2f64f05f7cb9deb4b3a53d7303ba70b0d73712"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344127\\/CTA-Poll-18-Risk-of-deviations-of-decentralized-virtual-clinical-trials-vs-traditional-trial-research",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "6e150c03d432ef833613cb919f86424d3457b753b7c35e5cb2b037ec69bf75c0"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90350250\\/Pharma-Poll-44-Regulatory-barrier-towards-adopting-software-enabled-practices",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "d568d7059563d635281bcc3dbfd1ef72bdc6a7fef938d3f55fb722a8a410d6e2"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90350253\\/Pharma-Poll-45-Main-design-challenge-of-RPM-technologies",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "28f861bdab5a59c5ce800463c830171359cdd3b670bb2ab4526ab7583576a370"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90350244\\/Pharma-Poll-42-Pharma-value-best-supported-by-Remote-Patient-Monitoring",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "692dc5fc9ed79ea73e8b0407eb0c0da72056f7cbe6c882e9e101a92842b63cc0"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344128\\/CTA-Poll-19-Mode-of-handling-data-collection",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "421ae8a979454bb88db66cc88ed06156952333e0c9283ae134d91e18a1c9acd0"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344119\\/CTA-Poll-13-Timeline-of-using-decentralized-virtual-clinical-trials",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "a16a9cd346ccca17cdf634b7c698f43dd44eb88eca01cc005d2e785b8c3ad080"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344118\\/CTA-Poll-12-Usage-of-decentralized-virtual-clinical-trials",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "0eed0b953e67171fd7f83578e4992336175505bc496c00462d3fb7248f07332c"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90350256\\/Pharma-Poll-46-Most-important-consideration-to-ensure-success-of-virtual-clinical-trials",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "60ecb60225375492f7f350008d881ed27c3926b86c4fc2ebaed7525f6ea37338"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344123\\/CTA-Poll-14-Impact-of-COVID-19-pandemic-on-clinical-trials",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "d435062a150215ae431f3d35c2bc729ae185949231f8f6a44771646f7261394b"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344131\\/CTA-Poll-21-Evaluation-of-data-management-solutions",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "854f8e8c7fbdf79cb85cfa0ae23a8ad7426372a8680231ce5dd48ab02a95db12"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {
                "permutive-id": 0.000013886285210411937
            },
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        }
    ],
    "categories": [],
    "performance": {},
    "cookies": 0.0000208,
    "types": {
        "Document": 68
    },
    "nameservers": [
        "ns-1912.awsdns-47.co.uk",
        "ns-440.awsdns-55.com",
        "ns-898.awsdns-48.net",
        "ns-1127.awsdns-12.org"
    ]
}